Image

Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching

Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching

Recruiting
All
Phase N/A

Powered by AI

Overview

The goal of this study is to learn if toolkits of implementation strategies (e.g., provider and staff education, clear plan for how to refer and bill) help pediatric type 1 diabetes medical and psychology providers deliver a behavioral intervention (Diabetes Coaching) to more families. The main questions this study aims to answer are:

  • Is it possible to put these toolkits of implementation strategies into place in one pediatric hospital?
  • Do providers and staff find these toolkits of implementation strategies acceptable?

Participants will be type 1 diabetes professionals (endocrinologists, nurse practitioners, psychologists, scheduling and billing staff) at Nemours Children's Hospital Delaware. Participants will:

  • Attend educational and/or planning meetings
  • Receive email updates on referral data
  • Complete surveys
  • Complete an interview

Description

Type 1 diabetes (T1D), one of the most prevalent chronic pediatric diseases in the United States, requires a complex treatment regimen. Youth with T1D, particularly adolescents, more frequently have higher glycemic levels. Less than 30% of youth achieve the recommended level of glycemic control. Compared to adults, youth are more at-risk for related complications (diabetic ketoacidosis) that can lead to heart disease, diabetic coma, and death. These complications often result from challenges completing T1D care tasks. Evidence-based behavioral interventions can increase T1D care task completion and lower glycemic levels (i.e., A1c). Integrating these interventions into standard T1D care may lead to better overall health for this population. Implementation science offers theory and rigorous methods to accomplish this goal, but few studies have employed them.

Behavioral Family Systems Therapy-Diabetes (BFST-D) is efficacious for increasing T1D care task completion and lowering A1c, particularly among adolescents who have higher glycemic levels (A1c≥9.0%). A brief 4-session, adapted version of BFST-D (Diabetes Coaching) delivered as part of standard care was associated with lowered glycemic levels. Despite these efficacy and initial effectiveness data, few receive this evidence-based care. Although Diabetes Coaching has been offered at the PI's institution, less than 10% of patients received it. Evaluation of strategies to improve reach of Diabetes Coaching in standard care is needed.

In a large national qualitative study of key informants (adolescents with T1D-caregiver dyads, medical and psychosocial healthcare providers, healthcare leaders) drawn from 5 children's hospitals, the PI identified determinants of implementing Diabetes Coaching (K23 Aim 1). Factors influencing implementation ranged across all domains of the Consolidated Framework for Implementation Research (CFIR), including those related to family needs and opportunity to engage in this care (evening, telehealth delivery, expert providers who are empathic, patient, encouraging, referrals from trusted provider when A1c rising, evidence of improved A1c), provider knowledge and self-efficacy in referring to and delivering Diabetes Coaching, and clinic resources (lack of streamlined referral processes; leadership buy-in), as well as external factors (insurance coverage).

Using these rich data and an evidence-based quality improvement (EBQI) approach with iterative feedback from Family and Healthcare Professional Diabetes Care Advisory Boards (F-DCAB; P-DCAB) drawn from Nemours Children's Hospital Delaware (NCHD), the PI developed a toolkit of implementation strategies (K23 Aim 2). Implementation strategies are methods for integrating evidence-based practices into standard care.20 Critical strategies needed to integrate Diabetes Coaching into standard T1D care at NCHD emerged and comprise a Base Implementation Toolkit (BIT). Pre-implementation BIT strategies include provider and staff education meetings (e.g., referring and delivering Diabetes Coaching), identification of and training of Champions for implementation, materials to increase demand for Diabetes Coaching among families (e.g., family-facing educational materials), and development of a workflow blueprint and of tools to monitor implementation. Active implementation BIT implementation strategies include feedback loop to clinical provider team regarding summary level data on uptake of referrals to and family engagement in Diabetes Coaching, as well as consultation to support problem-solving workflow and other implementation challenges with Champions. Two strategies (audit and feedback, adapting delivery format and timing of Diabetes Coaching) may be added to BIT (BIT-Enhanced) to improve adoption among medical providers with lower referral rates and/or to increase reach if few families attend Diabetes Coaching. BIT-Enhanced requires additional time and resources (e.g., Champion and providers review individual data, collaborate on ways to increase referrals). Thus, examining if this additional strategy meaningfully improves outcomes offers critical data for maintaining only the strategies that are necessary and sufficient. Key to maintaining implementation of any evidence-based practice, including Diabetes Coaching, is considering sustainability early on. The primary sustainability strategy involves training the Champions early and planful progression of their role in the implementation efforts, from first attending the PI-led (implementation and content expert) brief consultation meetings and data tracking to then independently leading these meetings (BIT-Sustainment)

Guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) and the Reach, Efficacy, Adoption, Implementation, Maintenance (RE-AIM) frameworks, the goals of the current single site pilot implementation feasibility trial (K23 Aim 3) are to pilot study procedures and the implementation toolkits and track effectiveness of implementation toolkits in preparation for a fully powered trial. The overarching aim of this study is to gather preliminary data to support an R01 application to conduct a large, multi-site randomized hybrid implementation-effectiveness trial testing uptake of Diabetes Coaching and tracking patient health outcomes.

Aim 1 (Feasibility \& Acceptability): Conduct a pilot implementation feasibility study at the PIs institution (NCHD) to examine acceptability and feasibility of BIT for Diabetes Coaching and BIT-Enhanced for providers with lower adoption rates (\<80%) and with low reach (\<5 families per group), and BIT-Sustainment. In addition, study procedures will be piloted in preparation for a fully powered trial.

Aim 2 (Implementation Outcomes): Examine four exploratory implementation outcomes, (1) medical provider adoption of referring to Diabetes Coaching (i.e., number of providers vs. number of providers referring \>80% eligible families), (2) psychologist fidelity in delivering Diabetes Coaching, and (3) reach of Diabetes Coaching to the target patient population (i.e., number families eligible vs. referred, number of sessions attended, completion rate). (4) Sustainability of adoption, reach, and fidelity will be examined following the removal of most research resources.

Eligibility

Inclusion Criteria:

  1. Involved in the direct clinical medical care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  2. Involved in the direct clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  3. Involved in the scheduling and/or insurance coverage verification in the clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  4. Holds a leadership role in Endocrinology and/or Behavioral Health at Nemours Children's Hospital - Delaware

Exclusion Criteria:

1\. Not involved in the direct clinical care or administrative parts of care of families with an adolescent with T1D at Nemours Children's Hospital - Delaware

Study details
    Implementation Science
    Type 1 Diabetes in Adolescence
    Implementation Strategies

NCT07766811

Nemours Children's Clinic

29 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.